Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anthony George Letai, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Anthony Letai and Danielle Potter.
Connection Strength

2.048
  1. Dynamic BH3 profiling identifies active BH3 mimetic combinations in non-small cell lung cancer. Cell Death Dis. 2021 07 27; 12(8):741.
    View in: PubMed
    Score: 0.984
  2. To Prime, or Not to Prime: That Is the Question. Cold Spring Harb Symp Quant Biol. 2016; 81:131-140.
    View in: PubMed
    Score: 0.709
  3. Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics. Sci Signal. 2021 Jun 08; 14(686).
    View in: PubMed
    Score: 0.244
  4. Adding venetoclax to fludarabine/busulfan RIC transplant for high risk MDS and AML is feasible, safe, and active. Blood Adv. 2021 Oct 06.
    View in: PubMed
    Score: 0.062
  5. ER Stress Signaling Promotes the Survival of Cancer "Persister Cells" Tolerant to EGFR Tyrosine Kinase Inhibitors. Cancer Res. 2018 02 15; 78(4):1044-1057.
    View in: PubMed
    Score: 0.048
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.